Letter to NYTimes

I sent my first "letter to the editor" today in reference to an article on the recent Vytorin efficacy trials. See for yourself.

----

"What That Cholesterol Trial Didn't Show" complains about panic amongst patients after news spread of the trial results. But the article failed to point out that the Times itself carries some blame. The article published last week titled "Drug Has No Benefit in Trial,
Makers Say" states,

"This trial was designed to show that Zetia could reduce the growth of those plaques. Instead, the plaques actually grew almost twice as fast in patients taking Zetia along with Zocor than in those taking Zocor alone."

It should be clear why readers are alarmed. Whether the claim is true or not, the Times should discuss its involvement in the panic. I don't believe doing so will reflect poorly on the Times, quite the opposite.


Thanks for your time and great articles,

Daniel Terry
Student, Computational Biology & Medicine
Cornell University, Weill Medical College